GlycoMimetics
GLYC
#10327
Rank
โ‚น0.91 B
Marketcap
โ‚น14.11
Share price
-5.42%
Change (1 day)
-42.53%
Change (1 year)

Revenue for GlycoMimetics (GLYC)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of โ‚น0.83 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for GlycoMimetics from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A-100%
2023 โ‚น0.83 M-86.59%
2022 โ‚น6.2 M-92.81%
2021 โ‚น86.32 M-88.39%
2020 โ‚น0.74 B
2019 N/A
2018 N/A
2017 N/A-100%
2016 โ‚น1.25 M-99.91%
2015 โ‚น1.33 B40.05%
2014 โ‚น0.95 B286.1%
2013 โ‚น0.24 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
bluebird bio
BLUE
โ‚น9.34 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.644 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น4.272 TN/A๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
โ‚น8.283 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA